2022 World Conference on Lung Cancer (ePosters)-EP04.01-027. Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis

EP04.01-027. Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis

Pdf Summary

This study examined the utilization and factors associated with pain interventions in stage IV non-small cell lung cancer (NSCLC). The study cohort included 13,159 patients with stage IV NSCLC, of which 68.5% reported at least one high pain score on the Edmonton Symptom Assessment System (ESAS). The results showed that patient-reported high pain was common in stage IV NSCLC, but most patients received interventions for pain, including palliative care or radiation therapy. The utilization of healthcare resources for pain management in this population was found to be high. The study also identified factors associated with interventions for pain in metastatic lung cancer, which can help inform symptom management. The findings highlight the importance of addressing pain in patients with stage IV NSCLC and emphasize the need for effective pain interventions in this population. The study was supported by funding from the Ontario Institute for Cancer Research. The corresponding author of the study is Dr. Alexander V. Louie from the Odette Cancer Centre at Sunnybrook Health Sciences Centre in Toronto, Canada.

Asset Subtitle

Vivian S Tan

Meta Tag

Speaker Vivian S Tan

Topic Global Health, Health Services Research, and Health Economics - Cost Issues

Keywords

utilization

factors

pain interventions

stage IV NSCLC

patient-reported high pain

palliative care

radiation therapy

healthcare resources

metastatic lung cancer

symptom management